文献速递衰弱、肌少症与跌倒老年综合评估

脂肪量在HMB与衰弱关联中占主导作用

Predominant role of fat mass in the association between HMB and frailty.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2025-01-01

该横断面研究基于Toledo健康老龄化队列中1257名≥65岁成人,采用双能X线吸收法评估身体成分,以衰弱特征量表(FTS-12)评估衰弱。结果显示HMB/身体成分比值与衰弱显著相关,且HMB/全身脂肪量比值的保护效应独立于瘦体重比值,提示脂肪量较瘦体重更能介导HMB与衰弱的关联。

要点

  • HMB/全身脂肪量比值与衰弱显著相关,且该保护效应独立于瘦体重比值。
  • HMB/全身脂肪量比值升高由HMB水平升高和脂肪量降低共同驱动。
  • HMB/全身瘦体重比值升高主要由HMB水平升高驱动,瘦体重保持恒定。

核心结论

  • 内源性HMB与衰弱的关系受身体成分修饰,脂肪量介导的影响强于瘦体重。

研究设计与样本

  • 横断面分析,数据来自Toledo健康老龄化队列中≥65岁成人,共分析1257人(女性56.72%,平均年龄74.6±5.95岁)。
  • 身体成分用双能X线吸收法评估全身瘦体重和全身脂肪量,衰弱用衰弱特征量表(FTS-12)评估。
  • 采用六个回归模型检验HMB/身体成分比值与衰弱的关联,调整年龄、性别、共病、腰臀比、营养状况和地中海饮食依从性。

主要发现

  • 男性HMB水平显著高于女性。
  • HMB/身体成分比值在男女两性中均与衰弱显著相关。
  • HMB/全身脂肪量比值升高由HMB水平升高(Q1:0.155±0.027 ng/mL vs Q4:0.280±0.057 ng/mL)和脂肪量降低(Q1:19.11±3.12 kg/m2 vs Q4:11.34±2.44 kg/m2)共同驱动。
  • HMB/全身瘦体重比值升高主要由HMB水平升高驱动(Q1:0.149±0.023 ng/mL vs Q4:0.292±0.05 ng/mL),瘦体重保持恒定(Q1:25.11±2.79 kg/m2 vs Q4:24.62±2.91 kg/m2)。

临床怎么用

  • 在评估老年衰弱时,应关注脂肪量而非仅关注瘦体重,HMB与衰弱的关联更强地由脂肪量介导。
  • 未来研究可探索HMB补充对年龄相关身体成分变化和衰弱的治疗意义。

局限性

  • 本研究为横断面分析,无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: β-Hydroxy-β-methylbutyrate (HMB) is a bioactive metabolite formed from the breakdown of leucine, which increases muscle protein synthesis and reduces muscle breakdown. Previous studies have shown an inverse association between HMB levels and frailty in older adults. This study aims to assess if body composition influences this association. METHODS: A cross-sectional analysis was conducted using data from a cohort of adults ≥65 years from the Toledo Study of Healthy Aging. Body composition [total lean (TBLM) and fat mass (TBFM)] was assessed using dual-energy X-ray absorptiometry. Frailty was assessed with the Frailty Trait Scale (FTS-12). Six regression models were employed to examine HMB/body composition ratios and frailty, adjusting by age, sex, comorbidity, waist-to-hip ratio, nutritional status, and Mediterranean diet adherence. RESULTS: Data from 1257 individuals (56.72% females, mean age 74.6 ± 5.95 years) were analyzed. Significantly higher values of HMB levels were observed in men compared to women. HMB/body composition ratios were significantly associated with frailty in both sexes. Increased HMB/TBFM ratios occurred due to both higher HMB levels (Q1: 0.155 ± 0.027 ng/mL vs Q4: 0.280 ± 0.057 ng/mL) and lower fat mass (Q1: 19.11 ± 3.12 kg/m2 vs Q4: 11.34 ± 2.44 kg/m2), whereas higher HMB/TBLM ratios were primarily driven by higher HMB levels (Q1: 0.149 ± 0.023 ng/mL vs Q4: 0.292 ± 0.05 ng/mL), whereas lean mass remained constant (Q1: 25.11 ± 2.79 kg/m2 vs Q4: 24.62 ± 2.91 kg/m2). The protective effect of the HMB/TBFM ratio was independent of the lean mass ratio. CONCLUSION: The relationship between endogenous HMB and frailty is modified by body composition, with a stronger impact mediated by fat mass than lean mass. Future studies should explore the therapeutic implications of HMB supplementation in age-related changes in body composition and frailty.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Molina-Baena B, Carnicero JA, Pereira SL, et al. Predominant role of fat mass in the association between HMB and frailty. J Gerontol A Biol Sci Med Sci. 2025. PMID: 41052294. doi:10.1093/gerona/glaf203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。